Alzheimer's Drug Helps Slow Down Development—Eisai, Biogen Proves in Clinical Trial It is a new cutting edge development to medicine in treating people with dementia. by Isaiah Richard
Chatbots Could Be Suffering from Confirmation Bias When Tackling Controversial Issues: John Hopkins Study